Dr. Talal Alharazi

Address:

Department of Clinical Laboratory Sciences,
College of Applied Medical Sciences,
University of Hail, Hail,
Kingdom of Saudi Arabia

Academic Metrics

• h-index: 11
• i-10 index: 14
• Total Citations: 424

Research Interests:

• Medical Parasitology
• Helminthology and Neglected Tropical Diseases (NTDs)
• Infectious Disease Epidemiology (HIV, HCV, HBV, Malaria)
• Intestinal Parasitic Infections
• Computational Drug Screening (In Silico Pharmacology)
• Nanomedicine and Nano-therapeutics

Biography:

Dr. Talal Alharazi is a highly experienced Professor specializing in Medical Parasitology and Infectious Disease Epidemiology. His scientific contributions focus on understanding the prevalence, risk factors, and distribution of parasitic diseases, including helminthology and neglected tropical diseases (NTDs), particularly in communities in Yemen and Saudi Arabia. Beyond traditional parasitology, his current research employs modern computational and nano-therapeutic approaches to combat global health issues like diabetes complications and cancer, demonstrating a commitment to translational public health solutions.

Professional Background

• Professor of Medical Parasitology (Current), Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, University of Ha'il, Saudi Arabia.
• Assistant Professor/Faculty, Medical Microbiology and Immunology Department, Faculty of Medicine, Taiz University, Yemen.

Achievements

• Extensive publication record addressing critical public health issues related to infectious and parasitic diseases in the Middle East.
• Pioneering research integrating computational drug screening and nano-therapeutics into parasitology and infectious disease management.

Current Research Projects

Dr. Alharazi's current work is dual-focused, investigating both epidemiological trends of parasitic infections and developing novel therapeutics:

• Epidemiological studies on the prevalence, knowledge, attitude, and practices related to intestinal parasitic infections and cutaneous leishmaniasis in endemic areas.
• Computational drug discovery, focusing on identifying natural inhibitors (e.g., from Cynomorium songaricum) for key enzymes involved in diabetic complications (ALR2).
• Research into nanomedicine and nano-therapeutics for cancer treatment.

Academic Profiles of Dr. Talal Alharazi

Explore his academic and professional presence across trusted platforms.

• ResearchGate
• Google Scholar

Publications:

Dr. Alharazi maintains a prolific publication record focusing on the translational research of advanced nanomaterials for environmental and engineering applications.

• Alshaghdali, K., Tasleem, M., Alharazi, T., & Saeed, A. (2025). An in silico Approach for Identification of Novel Natural Selective ALR2 Inhibitors from Cynomorium songaricum for Treating Diabetic Complications. Article (June 2025).
• Qanash, H., Bazaid, A. S., Alharazi, T., Barnawi, H., Alotaibi, K., Shater, A.-R. M., & Abdelghany, T. M. (2024). Bioenvironmental applications of myco-created bioactive zinc oxide nanoparticle-doped selenium oxide nanoparticles. Biomass Conversion and Biorefinery. DOI: 10.1007/S13399-023-03809-6.
• Khan, H., Shahab, U., Alshammari, A., Alyahyawi, A. R., Akasha, R., Alharazi, T., Ahmad, R., Khanam, A., Habib, S., & Kaur, K. (2024). Nano-therapeutics: The upcoming nanomedicine to treat cancer. IUBMB Life. DOI: 10.1002/IUB.2814.
• Khanam, A., Alouffi, S., Alyahyawi, A. R., Husain, A., Khan, S., Alharazi, T., Akasha, R., Khan, H., Shahab, U., & Ahmad, S. (2024). Generation of autoantibodies against glycated fibrinogen: Role in diabetic nephropathy and retinopathy. Analytical Biochemistry. DOI: 10.1016/j.ab.2023.115393.
• Saeed, A., Alharazi, T., Alshaghdali, K., Rezgui, R., Elnaem, I., Alreshidi, B. T., Tasleem, M., & Saeed, M. (2024). Targeting GluR3 in Depression and Alzheimer's Disease: Novel Compounds and Therapeutic Prospects. Journal of Alzheimer's Disease (January 2024). DOI: 10.3233/jad-230821.
   

Last Updated on September 30, 2025